Ukraine Parliament Votes to Legalize Medical Marijuana

Regulations by { "type": "", "title": "", "logo": "", "description": "", "auth": "", "seo_url": "" }

Dec.22.2023

Ukraine Parliament Votes to Legalize Medical Marijuana

Ukraine's Parliament votes to legalize medical marijuana following war-related PTSD cases, with strict control on production and sales.

On December 21st, the Ukrainian Parliament voted in favor of legalizing medical cannabis, following a war with Russia that has resulted in thousands of people suffering from post-traumatic stress disorder. Many believe that this condition can be alleviated through medication, according to a report by the Associated Press.

The new law will come into effect six months from now, allowing for the scientific and industrial use of marijuana. It was passed in the Kiev Parliament with 248 votes out of the 401 seats. Details of the voting were not provided at the time. The law was proposed by Prime Minister Denys Smyhal.

The possibility of legalizing medical cannabis has been a long-standing debate in Ukraine. Many people endorse the benefits of cannabis for medical treatment, while others express concerns that legalizing medical marijuana may result in an influx of drugs into Ukrainian urban streets.

The measure imposes strict control over the production and sale of marijuana. Any medication containing cannabis derivatives requires a prescription from a doctor. The recreational use of marijuana remains classified as a criminal offense.

References:

[1] Ucrania aprueba legalizar marihuana medicinal, luego de que guerra causara estrés a miles Agencias

Also Read:

[1] Controversy Surrounding the Legalization of Marijuana in Colombia

[2] Controversial Revisions Proposed for Ohio's Marijuana Legalization Initiative

[3] Ohio Voters Approve Proposal to Legalize Recreational Marijuana

[4] Health Problems on the Rise Since Cannabis Legalization

#Europe #Legislation #UK #CBD #Ukraine #The United Kingdom #Marijuana #European Parliament #Medical marijuana dispensary

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Breaking News | FDA Adds on! Plus Nicotine Pouches to PMTA-Authorized List

The U.S. Food and Drug Administration (FDA) has added ON! Plus nicotine pouch products to its list of authorized products, disclosing that the brand has received Marketing Granted Orders (MGO) through the Premarket Tobacco Product Application (PMTA) pathway. The update makes on! Plus the second nicotine pouch brand authorized via PMTA, following ZYN. As of publication, the FDA had not issued a separate press release on the decision.

News

Dec.20 by { "username": "", "position": "", "avatar": "", "auth": "", "seo_url": "" }

Azerbaijan Parliament Passes E-cigarette Ban Bill in First Reading

Azerbaijan’s Milli Majlis has approved, in its first reading, a bill that would ban the import, export, production, storage, wholesale and retail sale, and use of electronic cigarettes and their components. The bill amends the Law on Tobacco and Tobacco Products, classifying nicotine-containing e-cigarettes as tobacco products while explicitly excluding heated tobacco products. If adopted, the law would take effect on February 1, 2026.

Dec.22 by { "username": "", "position": "", "avatar": "", "auth": "", "seo_url": "" }

Selangor preparing regulatory policy that may gradually prohibit vape use

Selangor is drafting a policy paper outlining its regulatory direction for electronic cigarette products, including the possibility of gradually prohibiting vape use. The move aligns with the Tobacco Product Control Act for Public Health 2023 (Act 852) and aims to strengthen enforcement and youth health education.

Nov.21 by { "username": "", "position": "", "avatar": "", "auth": "", "seo_url": "" }

Russia’s Vape Market Squeezed by Excise Hikes and Criminal Marking Rules